Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein

被引:31
作者
Abel, RL
Haigis, MC
Park, C
Raines, RT
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA
关键词
competition assay; equilibrium dissociation constant; fluorescence spectroscopy; protein-protein interaction; ribonuclease A; ribonuclease inhibitor;
D O I
10.1006/abio.2002.5678
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Ribonuclease A (RNase A) and the ribonuclease inhibitor protein (111) form one of the tightest known protein-protein complexes. RNase A variants and homologues, such as G88R RNase A, that retain ribonucleolytic activity in the presence of RI are toxic to cancer cells. Herein, a new and facile assay is described for measuring the equilibrium dissociation constant (K-d) and dissociation rate constant (k(d)) for complexes of RI and RNase A. This assay is based on the decrease in fluorescence intensity that occurs when a fluorescein-labeled RNase A binds to RI. To allow time for equilibration, the assay is most readily applied to those complexes with K, values in the nanomolar range or higher. Using this assay, the value of Kd for the complex of RI with fluorescein-labeled G88R RNase A was determined to be 0.55 +/- 0.03 nM. In addition, the value of K, was determined for the complex of RI with unlabeled G88R RNase A to be 0.57 +/- 0.05 nM by using a competition assay with fluorescein-labeled G88R RNase A. Finally, the value of kd for the complex of RI with fluorescein-labeled G88R RNase A was determined to be (7.5 +/- 0.4) x 10(-3) s(-1) by monitoring the increase in fluorescence intensity upon dissociation. This assay can be used to characterize complexes of RI with a wide variety of RNase A variants and homologues, including those with cytotoxic activity. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:100 / 107
页数:8
相关论文
共 42 条
[1]  
Badet J, 1999, PATHOL BIOL, V47, P345
[2]   MOLECULAR EVOLUTION OF THE RIBONUCLEASE SUPERFAMILY [J].
BEINTEMA, JJ ;
SCHULLER, C ;
IRIE, M ;
CARSANA, A .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1988, 51 (03) :165-192
[3]   Role of the N terminus in RNase a homologues: Differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity [J].
Boix, E ;
Wu, YN ;
Vasandani, VM ;
Saxena, SK ;
Ardelt, W ;
Ladner, J ;
Youle, RJ .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 257 (05) :992-1007
[4]   A ribonuclease A variant with low catalytic activity but high cytotoxicity [J].
Bretscher, LE ;
Abel, RL ;
Raines, RT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :9893-9896
[5]   Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A [J].
Chen, CZ ;
Shapiro, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1761-1766
[6]   Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A [J].
Chen, CZ ;
Shapiro, R .
BIOCHEMISTRY, 1999, 38 (29) :9273-9285
[7]  
CUCHILLO CM, 1997, RIBONUCLEASES STRUCT, P271
[8]   ENGINEERING RIBONUCLEASE-A - PRODUCTION, PURIFICATION AND CHARACTERIZATION OF WILD-TYPE ENZYME AND MUTANTS AT GLN11 [J].
DELCARDAYRE, SB ;
RIBO, M ;
YOKEL, EM ;
QUIRK, DJ ;
RUTTER, WJ ;
RAINES, RT .
PROTEIN ENGINEERING, 1995, 8 (03) :261-273
[9]   THIOL-DISULFIDE EXCHANGE OF RIBONUCLEASE INHIBITOR BOUND TO RIBONUCLEASE-A - EVIDENCE OF ACTIVE INHIBITOR-BOUND RIBONUCLEASE [J].
FERRERAS, M ;
GAVILANES, JG ;
LOPEZOTIN, C ;
GARCIASEGURA, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) :28570-28578
[10]   RECOMBINANT HUMAN PANCREATIC RIBONUCLEASE PRODUCED IN ESCHERICHIA-COLI - IMPORTANCE OF THE AMINO-TERMINAL SEQUENCE [J].
FUTAMI, J ;
SENO, M ;
KOSAKA, M ;
TADA, H ;
SENO, S ;
YAMADA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (01) :406-413